Assignee
CEREVANCE INC
US·0 granted patents·4 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
4 records- 0164US2025282728A1Nitrogen comprising heterocyclic derivatives for the treatment of disorders associated with gpr55 receptorCEREVANCE INC·Filed 2023·Application pending·0 cites
- 0261US2025019369A1N-(4-aminocyclohexyl)pyrimidine-4-carboxamide derivatives as CD38 inhibitorsCEREVANCE INC·Filed 2022·Application pending·0 cites
- 0358US2024158385A1Novel compoundsCEREVANCE INC·Filed 2022·Application pending·0 cites
- 0452US2024059677A1Substituted pyrimidine derivatives as nicotinic acetylcholinesterase receptor alpha 6 modulatorCEREVANCE INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →